Trial Profile
Trial of Sinovac's measles mumps and rubella virus vaccine in China
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2015
Price :
$35
*
At a glance
- Drugs Measles mumps and rubella vaccine Sinovac Biotech (Primary)
- Indications Measles; Mumps; Rubella
- Focus Adverse reactions
- 25 Mar 2015 New trial record
- 17 Mar 2015 The clinical trial application for this study of measles mumps and rubella virus vaccine was filed with the China Food and Drug Administration in April 2011, and Sinovac obtained the clinical trial license in December 2014, according to a company media release.